Biotech’s Biggest IPO, Obesity Pills, and RNA’s Secret
Kilder
- BioPharma Dive: AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine
- Finance: AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine - Yahoo Finance
- STAT: STAT+: Your sepsis algorithm shouldn’t require a time machine
- BioPharma Dive: Parabilis sets a record with a $670M biotech IPO
- BioSpace: Update: Parabilis raises industry-record $670M IPO - BioSpace
- Finance: Parabilis Medicines sets biotech record with $670m IPO - Yahoo Finance
- GEN: Innovative Tech Testing in Response to GMP Revisions
- GEN: mRNA Tails Play Key Role in Folding Regulatory Proteins - Genetic Engineering and Biotechnology News
- GEN: Updated Amplification Tool Rapidly Detects Mycoplasma - Genetic Engineering and Biotechnology News
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.